AU Stock MarketDetailed Quotes
RGT Argent Biopharma Ltd
- 0.290
- -0.015-4.92%
20min DelayMarket Closed Jul 24 13:40 AET
13.13MMarket Cap-40P/E (Static)
0.350High0.275Low681.71KVolume0.310Open0.305Pre Close215.24KTurnover0.45052wk High2.51%Turnover Ratio45.28MShares0.25052wk Low-3.206EPS TTM7.87MFloat Cap0.450Historical HighLossP/E (Static)27.12MShs Float0.250Historical Low-7.1EPS LYR24.59%Amplitude--Dividend TTM9.67P/B1Lot Size--Div YieldTTM
About Argent Biopharma Ltd Company
Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development.
Company Profile
SymbolRGT
Company NameArgent Biopharma Ltd
Founded2005
MarketASX
Employees16
Fiscal Year Ends06-30
Address295 Rokeby Road Suite 1
CitySubiaco
CountryAustralia
Zip Code6008
Phone+61 865552950
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 850 505
Company Executives
- Name
- Position
- Salary
- Roby Zomer
- Executive Director,Managing Director and Chief Executive Officer
- 354.02K
- Dr. Stephen Barry Parker
- Non-Executive Director,Senior Independent Director and Interim Chairman
- 30.59K
- Layton Mills
- Non-Executive Director
- --
- Dr. Ross Walker
- Non-Executive Director,Head of Clinical Advisory Team
- 44.00K
- Rowan Harland
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg